ASTRO Town Hall Discussion (Poll % on site)

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Necessary percent of time on site for RadOncs

  • 100%

  • 90%

  • 75%

  • 50%

  • 25%

  • 10%

  • 0%


Results are only viewable after voting.
In the FAQs, they do mention no show tele-supervision, but my take is their main concern is the values of some radiation FFS codes reliant on physician presence. Of course, they're also trying to do away with the current FFS codes for most diagnoses via ROCR. So who knows? Are they just looking to protect the FFS codes for the tech exempted from ROCR? Probably.

I don't understand this.

77427 is worth 3.37 wRVU. That's always in person, and even if it weren't E&M can already be done virtually if needed/desired, and the code encompasses 5 days worth of work.
Our treatment planning codes... what does that matter where they are done? The IGRT codes... we've already been through this.
So if this presumably is to protect the RVU rates for the technical codes, then most of us don't get these anyway.
If I'm going to have to be onsite an extra 50% or more to protect the technical codes, then I, uhh, want some of the technical revenue.

Members don't see this ad.
 
  • Like
Reactions: 7 users
I don't understand this.

77427 is worth 3.37 wRVU. That's always in person, and even if it weren't E&M can already be done virtually if needed/desired, and the code encompasses 5 days worth of work.
Our treatment planning codes... what does that matter where they are done? The IGRT codes... we've already been through this.
So if this presumably is to protect the RVU rates for the technical codes, then most of us don't get these anyway.
If I'm going to have to be onsite an extra 50% or more to protect the technical codes, then I, uhh, want some of the technical revenue.
Correct.

From the FAQ:
Many radiation therapy services specifically include physician presence in the CPT code descriptor and are valued accordingly. Changes in physician presence can impact valuation, therefore a shift to virtual supervision is likely to result in reduced reimbursement to radiation oncologists for services.
 
  • Like
Reactions: 1 users
Is it alarming to anyone else that two of the biggest/loudest voices on rad onc policy issues (though on different ends of their stance on some of these issues) are not actual physicians....and their livelihoods are based upon shaping policy decisions to benefit their businesses?
Rons biggest client is supposedly the ny proton center.
 
  • Haha
  • Okay...
  • Like
Reactions: 4 users
Members don't see this ad :)
100% agree.

THey also need to not dance around the question (and be VERY clear) of if direct supervision is needed, is it allowable to have an NP/PA do this with the the doc as back up general.

It was decided 5 years ago. General supervision in hospitals.
Is this going to be an issue that is constantly challenged every year? If so, why would anyone ever take a solo position without backup? If that's true, I screwed up leaving my exploitative PP gig. Add this to the long list of things that the covid debacle ruined.

I would advise any new grad at this point to try and get the highest salary guarantee they possibly can off the bat. Do you really want to be looking at an eat-what-you-kill model with this level of uncertainty, especially if this involves a few years of associate pay to get there.
 
Last edited:
  • Like
Reactions: 1 users
I heard it isn't just one thing but a combination of things. There is that ongoing lawsuit in NY about tele health. Then Bridge became associated with NY Proton through an attending and they are ready to pounce. There is panic that this will be a race to the bottom. Of course the big boogy men like MDACC/Washu/Mayo et al are totally silent on this. They will absolutely pounce on this to take over clinics. They already believe what they do is better.
 
Last edited:
  • Like
Reactions: 7 users
Last edited:
  • Like
Reactions: 1 users
In the FAQs, they do mention no show tele-supervision, but my take is their main concern is the values of some radiation FFS codes reliant on physician presence. Of course, they're also trying to do away with the current FFS codes for most diagnoses via ROCR. So who knows? Are they just looking to protect the FFS codes for the tech exempted from ROCR? Probably.
I actually think leadership is aware of the tinderbox that is the radonc job market and the tenuousness of radonc compensation.

We shouldn't think they are so stupid. Caveat...I speak to none of them.

ASTRO's actions regarding ROCR and now supervision are consistent with a group of leaders that believe that the floor is going to fall out from under them in the very near future. They may know things that we do not?

Their best bet at preserving compensation and a tenuous job market in general terms? Case based payment and direct supervision requirements.

Most of us would prefer case based payment in terms of day to day operations.

The proton carve outs are the unconscionable thing...picking winners based on scale and prestige, while not providing high level evidence of differential clinical value.

The glut of radoncs changes everything of course. Every other specialty has a shortage: Neurology...managing CVA and doing intra-op monitoring remotely. Psych...talk about that national license...we need it for psych. There are extraordinarily limited mental health resources outside of big cities. Medonc...APPs doing everything but prescribe the chemo (they do that as well some places). Medonc as manager will be the new role.

But in my practice...if I devalued presence and hired an APP...we could cut the number of docs in half. This is in a locale where we are actively trying to double the number of permanent medoncs, ENT, urology, surge-oncs, PCPS, etc.
 
  • Like
Reactions: 5 users
Is it alarming to anyone else that two of the biggest/loudest voices on rad onc policy issues (though on different ends of their stance on some of these issues) are not actual physicians....and their livelihoods are based upon shaping policy decisions to benefit their businesses?
YES!!!!!!

I've met him in person and I'm like yo, what are your goals here?!
 
  • Like
Reactions: 1 user
I saw multiple posts on this , i think Sean Mcbride from MSK might have posted about this. It is a lawsuit regarding allowing tele care. I have not looked into it beyond this. Places like MSK see tele care as something they can use to dominate markets even more . The argument is it is good for patients.
Oh... this is telehealth. Not direct virtual supervision per se. They sort of dovetail but mostly not.
 
  • Like
Reactions: 1 user
Oh... this is telehealth. Not direct virtual supervision per se. They sort of dovetail but mostly not.
Yeah but for example places like MSK would love to do tele for surrounding states (NY, CT,NJ, etc etc) and if telesupervision is widely kosher they will expand on this, i suspect.

I imagine a place like NYP center doing tele all over, could easily supervise remote areas and funnel patients to protons PRN.
 
Last edited:
  • Like
Reactions: 4 users
Agreed, telesupervision will be worse for RadOncs than anything we've seen before.
 
  • Like
Reactions: 1 users
Members don't see this ad :)
I have no clue what started the need for the letter. And I also don't know who actually has the ear of CMS. Seemingly the people that are most involved (again, maybe this is just conjecture based on social media) are ASTRO, Ron, Jordan/Bridge, and ACRO.

I would argue no other "outsider" (separate from ASTRO or some big letter organization) knows the history (not immediately related to the letter, just the history of supervision) on this issue better than Jason Bekta though.
*best Lurch impression*

"You rang?"

I genuinely don't believe there's a singular narrative/"red thread" that brought us to this point.

However, what's happening now is exactly what I expected would have happened in 2020 if the pandemic hadn't taken place.

What's lost in this conversation is the relatively "newness" of the Supervision rules themselves. So, taking a very high-level view of the timeline over the last 30 years, here's my best guess:

1) The majority of the people in traditional/establishment "leadership" positions today are in the 55 to 75-year-old age range. These people did their RadOnc residencies in the late 80's and the 1990's. At that time, there were severe concerns about oversupply as well, and RadOnc was very uncompetitive. Unlike today, programs responded by significantly reducing spots.

2) CMS introduced supervision rules for freestanding centers in the late 90s/early 2000s. There were more practices billing freestanding radiotherapy than today, but it doesn't appear to have caused a huge uproar like it does now. However, this could just be an artifact of the immature internet and lack of digital "stuff"/archives.

3) Early 2000s, IMRT, gravy train. RadOnc jumped into hyperspace by accident, not through planned/coordinated leadership.

4) In 2007-2009, the political landscape focused on Healthcare. The ACA ("Obamacare") was passed. This was the time of the "UroRads Troubles" and the attempt at using Stark Law to fend them off.

5) CMS issued a "clarification" in 2009 that the Supervision rules applied to hospital outpatient departments too. Everyone lost their minds. Very upset. CMS stuck to their guns and, by 2010/2011, Direct Supervision for hospital outpatient departments was clearly the law of the land.

6) The political focus on Healthcare created, in part, the "Radiation Boom" series in the New York Times. We had the high-profile MIMA (Todd) whistleblower case. Then, in 2012, we had the SGR publication making claims about how "expensive" radiotherapy was. The SGR metrics were discontinued shortly thereafter because the government realized it was dumb. Sadly, the damage was done.

7) From 2012-2015 there was intense interest in cutting/bundling radiotherapy reimbursement concurrently with the pop culture concerns about safety. ASTRO and other entities adopted a defense strategy which, in retrospect, was highly ineffective.

8) In the culture of RadOnc, all of these became dogmatically tied together. Supervision/safety/whistleblower, and then those pieces got wrapped into the reimbursement defense. Specifically today, we see the "understanding" that the OTV code was "preserved" as part of the supervision/safety/whistleblower dogma.

9) The bundling happened in 2015. Then there was a brief period of quiet. Then CMMI came out with the RO-APM proposal. Supervision and other issues took a backseat. RO-APM became the all-consuming battle.

10) Starting in 2012/2013 with the "Pendulum" aka "Bloodbath" article, the concerns about oversupply started to return. These concerns were ignored and derided.

11) ...to the detriment of everyone. We all know what happened starting in 2018.

12) The direct-to-general switch was announced in November 2019, ASTRO reacted in December 2019, it took place in January 2020.

13) Pandemic happened while RadOnc became the least desirable specialty in medicine.

14) Also, we've been in a ~14 year campaign for hypofrac/omission. Don't get me wrong, I think in many cases this is good for patients. However, it's extremely unbalanced, in that the optics of doing this appears, to the outside world, that even the radiation doctors want to get rid of radiation.

So throughout this time we've had the 22-year tenure of the now-retiring ASTRO CEO. We've had the same rotating cast of people in "leadership" positions. Where they work and their obvious biases have been discussed at length on SDN.

As I am fond of pointing out on social media and podcasts, ASTRO went on a whirlwind tour over the last ~18 months of making "unforced errors". They were on the cusp of rehabilitating their reputation during the year Eichler was ASTRO president and the Workforce Taskforce was announced.

Sadly, it turned into an unmitigated disaster.

Longwinded, I know, but it sets the stage for my hypothesis as to "why".

The current 22-year ASTRO/RadOnc era has been dominated by reaction, not action.

It was coincidence the era started with the rise in IMRT. UroRads? Reaction. Supervision and whistleblower? Reaction. New York Times? Reaction. SGR and cries of "costly radiation"? Reaction. Bundling of codes? Reaction. RO-APM? Reaction. Concerns of job market? Boards? Crash of competitiveness?

All reaction.

With the permanent tabling of RO-APM, and the country's focus on the pandemic, we've been in a period of minimal external threats to the specialty. However, the specialty is at a very low point.

The Workforce bungling, ROCR surprise, Direct Supervision necromancy...this is ASTRO taking action, unprompted. They know we're at a low point. They know something needs to be done.

They lack the skills or experience to get it done.

Because we're clearly coming to a point where CMS needs to decide whether or not Virtual Direct becomes permanent, ASTRO decided they need to throw their hat in the ring.

Because RadOnc is a bunch of W2 employees with very dogmatic views of the world, Bridge, a curious startup with a guy who struggles to maintain strong optics on social media, became a real point of fear for people.

I'm personally agnostic about Bridge. I think it has the same chances of success as any small business/startup in a highly regulated space. Startups in medicine...struggle.

Until the current echo chamber of establishment leadership steps aside or retires, I absolutely expect further "unforced errors", until/unless another external threat occurs for them to react to.
 
  • Like
  • Love
Reactions: 9 users
*best Lurch impression*

"You rang?"

I genuinely don't believe there's a singular narrative/"red thread" that brought us to this point.

However, what's happening now is exactly what I expected would have happened in 2020 if the pandemic hadn't taken place.

What's lost in this conversation is the relatively "newness" of the Supervision rules themselves. So, taking a very high-level view of the timeline over the last 30 years, here's my best guess:

1) The majority of the people in traditional/establishment "leadership" positions today are in the 55 to 75-year-old age range. These people did their RadOnc residencies in the late 80's and the 1990's. At that time, there were severe concerns about oversupply as well, and RadOnc was very uncompetitive. Unlike today, programs responded by significantly reducing spots.

2) CMS introduced supervision rules for freestanding centers in the late 90s/early 2000s. There were more practices billing freestanding radiotherapy than today, but it doesn't appear to have caused a huge uproar like it does now. However, this could just be an artifact of the immature internet and lack of digital "stuff"/archives.

3) Early 2000s, IMRT, gravy train. RadOnc jumped into hyperspace by accident, not through planned/coordinated leadership.

4) In 2007-2009, the political landscape focused on Healthcare. The ACA ("Obamacare") was passed. This was the time of the "UroRads Troubles" and the attempt at using Stark Law to fend them off.

5) CMS issued a "clarification" in 2009 that the Supervision rules applied to hospital outpatient departments too. Everyone lost their minds. Very upset. CMS stuck to their guns and, by 2010/2011, Direct Supervision for hospital outpatient departments was clearly the law of the land.

6) The political focus on Healthcare created, in part, the "Radiation Boom" series in the New York Times. We had the high-profile MIMA (Todd) whistleblower case. Then, in 2012, we had the SGR publication making claims about how "expensive" radiotherapy was. The SGR metrics were discontinued shortly thereafter because the government realized it was dumb. Sadly, the damage was done.

7) From 2012-2015 there was intense interest in cutting/bundling radiotherapy reimbursement concurrently with the pop culture concerns about safety. ASTRO and other entities adopted a defense strategy which, in retrospect, was highly ineffective.

8) In the culture of RadOnc, all of these became dogmatically tied together. Supervision/safety/whistleblower, and then those pieces got wrapped into the reimbursement defense. Specifically today, we see the "understanding" that the OTV code was "preserved" as part of the supervision/safety/whistleblower dogma.

9) The bundling happened in 2015. Then there was a brief period of quiet. Then CMMI came out with the RO-APM proposal. Supervision and other issues took a backseat. RO-APM became the all-consuming battle.

10) Starting in 2012/2013 with the "Pendulum" aka "Bloodbath" article, the concerns about oversupply started to return. These concerns were ignored and derided.

11) ...to the detriment of everyone. We all know what happened starting in 2018.

12) The direct-to-general switch was announced in November 2019, ASTRO reacted in December 2019, it took place in January 2020.

13) Pandemic happened while RadOnc became the least desirable specialty in medicine.

14) Also, we've been in a ~14 year campaign for hypofrac/omission. Don't get me wrong, I think in many cases this is good for patients. However, it's extremely unbalanced, in that the optics of doing this appears, to the outside world, that even the radiation doctors want to get rid of radiation.

So throughout this time we've had the 22-year tenure of the now-retiring ASTRO CEO. We've had the same rotating cast of people in "leadership" positions. Where they work and their obvious biases have been discussed at length on SDN.

As I am fond of pointing out on social media and podcasts, ASTRO went on a whirlwind tour over the last ~18 months of making "unforced errors". They were on the cusp of rehabilitating their reputation during the year Eichler was ASTRO president and the Workforce Taskforce was announced.

Sadly, it turned into an unmitigated disaster.

Longwinded, I know, but it sets the stage for my hypothesis as to "why".

The current 22-year ASTRO/RadOnc era has been dominated by reaction, not action.

It was coincidence the era started with the rise in IMRT. UroRads? Reaction. Supervision and whistleblower? Reaction. New York Times? Reaction. SGR and cries of "costly radiation"? Reaction. Bundling of codes? Reaction. RO-APM? Reaction. Concerns of job market? Boards? Crash of competitiveness?

All reaction.

With the permanent tabling of RO-APM, and the country's focus on the pandemic, we've been in a period of minimal external threats to the specialty. However, the specialty is at a very low point.

The Workforce bungling, ROCR surprise, Direct Supervision necromancy...this is ASTRO taking action, unprompted. They know we're at a low point. They know something needs to be done.

They lack the skills or experience to get it done.

Because we're clearly coming to a point where CMS needs to decide whether or not Virtual Direct becomes permanent, ASTRO decided they need to throw their hat in the ring.

Because RadOnc is a bunch of W2 employees with very dogmatic views of the world, Bridge, a curious startup with a guy who struggles to maintain strong optics on social media, became a real point of fear for people.

I'm personally agnostic about Bridge. I think it has the same chances of success as any small business/startup in a highly regulated space. Startups in medicine...struggle.

Until the current echo chamber of establishment leadership steps aside or retires, I absolutely expect further "unforced errors", until/unless another external threat occurs for them to react to.
If I had a magic wand and became ASTRO, I would do one thing:

A massive, thundering, pro-radiation PR campaign.

Pull in Varian and Elekta, MIM, Radformation, Civco - even my mortal enemy, the Goo Guys.

For the next 3-5 years, all we should hear about is the safety, efficacy, and VALUE that radiotherapy brings to the table.

And it needs to be done SO THE ACTUAL REST OF THE WORLD SEES IT.

Because the Spring edition of "ASTRO News" came out this week.

It's dedicated to benign radiotherapy. Including arthritis.

Does anyone know that?

I'm not a member so I don't get any emails. I follow ASTRO's website and social media presence closely, though.

You can find it on the website if you go specifically looking for it.

But...this is a very positive, important thing they did.

Don't they want anyone to know about it?
 
  • Like
Reactions: 7 users
Not widely utilized, yet
Not what I've heard when it comes to a significant chunk of centers over at GenesisCare.

My point is that people have the freedom to abuse it now in all likelihood and I just don't think we are seeing that to any large degree.
 
  • Like
Reactions: 1 users
can a radonc be ceo of ASTRO?
from 2022 form 990
1712771069916.png
 
  • Like
Reactions: 1 users
can a radonc be ceo of ASTRO?
from 2022 form 990
View attachment 385297

This is an interesting topic. We just interviewed Cliff Hudis, CEO of ASCO, on the podcast. It is all about organizational management and his career doing those roles. I hope you enjoy it.

We asked him about this specifically and ultimately decided to broaden the question to ask more generally about physician versus non physician leaders in organized medicine.

ASCO mandates an all-MD board of directors with representation from Rad Onc as well as an international MD board member. I personally think the company is run super well; to me this has to be part of it.

He gives kind of a balanced answer that I think is fair, there is some upside to having non-physicians in these roles and a highly successful non-physician healthcare leader is likely to have better management skills than some physician who is president of a society because he "put in his time".

Anyway, this is one of the things on my short list that would pique my interest in ASTRO again... if they hired an MD CEO. I think there is virtually no chance this happens, but hey. They latest town hall was a real town hall. Anything is possible.
 
  • Like
  • Care
Reactions: 3 users
Previous ASTRO CEO chosen because of relationship with American Hospital Association and Big Medicine. Some considered it a lateral move at the time.
 
  • Like
Reactions: 2 users
I have no clue what started the need for the letter. And I also don't know who actually has the ear of CMS. Seemingly the people that are most involved (again, maybe this is just conjecture based on social media) are ASTRO, Ron, Jordan/Bridge, and ACRO.

I would argue no other "outsider" (separate from ASTRO or some big letter organization) knows the history (not immediately related to the letter, just the history of supervision) on this issue better than Jason Bekta though.

I think the people who ACTUALLY have the ear of CMS aren't going to publicly broadcast their hopes/desires, hoping to get someone to agree with them. If ASTRO actually had the ear of CMS, this would be a back-channel conversation, not an official letter.
 
  • Like
Reactions: 4 users
I think the people who ACTUALLY have the ear of CMS aren't going to publicly broadcast their hopes/desires, hoping to get someone to agree with them. If ASTRO actually had the ear of CMS, this would be a back-channel conversation, not an official letter.

This may be right.

I think the inertia of virtual supervision is just too strong to create some unique cut out for rad onc (though I'd personally like to see 80% direct in person...what I want matters none). In my hospital I have pulm/cc running ICU's at our sister rural hospitals via monitors. Neuro intensivists seeing stroke patients virtually, etc.

As others have said in this thread, the underlying unifying voice of our leaders should be our value and worth and expanding role of radiation. Whether that be via video screen or in person.
 
  • Like
Reactions: 3 users
I just don’t see how there is a workable mechanism for a percent of supervision presence from cms’ perspective. And they are not going to have complicated carve out for radonc. also very likely that the cms burueocracts think Dave Adler and Astro are a bunch of losers.
 
  • Like
Reactions: 7 users
I just don’t see how there is a workable mechanism for a percent of supervision presence from cms’ perspective.

yeah, that's an issue. I'm not putting some app on my phone either.
But the "threat" of an audit may be enough to keep away virtual vultures.
Some medicare LCD's have some X% in person requirement in place now, so they must have some language about how that is tracked?
 
  • Like
Reactions: 1 user
I like the 60-80% idea BUT anytime you bring up these percentages - how are they tracked?
I'd rather spend 5 days in clinic than be lorded over by a clock punching mechanism
 
  • Like
Reactions: 2 users
As others have said in this thread, the underlying unifying voice of our leaders should be our value and worth and expanding role of radiation. Whether that be via video screen or in person
Agreed, and our worth does not lay in babysitting linacs.
 
  • Like
  • Care
Reactions: 1 users
This may be right.

I think the inertia of virtual supervision is just too strong to create some unique cut out for rad onc (though I'd personally like to see 80% direct in person...what I want matters none). In my hospital I have pulm/cc running ICU's at our sister rural hospitals via monitors. Neuro intensivists seeing stroke patients virtually, etc.

As others have said in this thread, the underlying unifying voice of our leaders should be our value and worth and expanding role of radiation. Whether that be via video screen or in person.

This is the main issue as I see it. I do enough SBRT/HDR so I'm always going to have to be in clinic, and as a result this discussion isn't going to personally effect me. However, requesting a return to direct supervision when all of medicine is headed in the other direction seems misguided.
 
  • Like
Reactions: 4 users
I like the 60-80% idea BUT anytime you bring up these percentages - how are they tracked?
I'd rather spend 5 days in clinic than be lorded over by a clock punching mechanism
The answer is the same for both Direct Supervision or 80% on-site:

Whistleblowers.

Because let's say you're following Direct Supervision rules. Let's say the design of your hospital is that the main clinic/treatment area with the linac is in its own distinct area. The physician offices are 50 feet down the hall, nearby but in a distinct area.

Let's say there are some small exam rooms in the treatment area, but there's a bigger "multi-disciplinary clinic" where you see most of your patients.

Unless you're in the treatment area, or someone comes to your office to find you - how do they know you're there?

What if your tumor board is on the third floor?

What if that tumor board is at 3PM and your linac generally treats till 4PM? And tumor board meets on the 3rd floor, which is also where the walkway to the parking deck is?

If tumor board gets out at 3:30PM, are you going back down to your office for 30 minutes?

(I know, I know - some of you losers would)

Everyone should go read the actual court documents from the existing RadOnc whistleblower cases. Because the question your asking is central to those cases.

That's why there's almost ALWAYS some other component.

In the MIMA/Todd case, for example, it required the whistleblower documenting when the infamous RadOnc was CLEARLY not physically on campus, and this was able to be corroborated (traveling to give an industry talk). But that wasn't enough then, and wouldn't be enough now. Because MIMA created the very first remote offline review (IGRT) using smartphones (before everyone knew the term "smartphone"), the government pulled the cell phone records and "proved" that the images were not actually reviewed because no cellular data had been used...not accounting for the fact that Wi-Fi exists.

And therein lies the problem for ALL OF THIS.

It's why Ronny D's business is soaring. It's why he and his company give talks everywhere.

This system only functions based on honor and fear.

Direct Supervision has NEVER stipulated what type of doctor needed to be "immediately available". The government refuses whistleblower cases all the time, the case needs to be strong and also have a sizeable payout on the table. I can't think of any RadOnc whistleblower cases with less than $500,000 at stake, but usually, it's over $1 million.

Or, for 21C - way, WAY more than $1 million.

While it's possible some hospitals would make their RadOncs punch a clock...I don't think that is the likely scenario in most places. If, for no other reason, than inertia and expense. It's not normal for hospitals to do that, and this would be a big shift in direction. Then you would either have to build out the hospital's existing timecard system to include RadOncs and some tracking mechanism, and have someone to review the data, etc etc etc. The cost wouldn't be zero.

But even if the became a minimum of 80% on site, and there was a whistleblower case, and the government agreed to pursue it...

Well, 80% of...what? Time the linac is on? Time the doctor is performing clinical tasks, including chart review and notes and contouring? Those aren't static values. Especially when you need to determine a time period. If it's 80% per week, and some RadOnc is on site 95-100% of the time most of the year, but has a week in February and a week in October where there were family emergencies and they were only on site 50% of the time - did they follow the law or break it?

And if it goes by day of the week, so 4 out of 5 days on site - that metric is uneven nationally if one hospital has 9 on beam while another has 59.

Anyway, my point, as always, is none of these systems are perfect. There are loopholes in all of them.

And it doesn't matter anyway because ASTRO is a joke to CMS, Virtual Direct will be permanent.
 
  • Like
Reactions: 5 users
ASTRO publicly posted the town hall recording.


HIGHLIGHTS:
18:30 .... @Rad Onc SK says we are in a supervision nirvana, and it must end
22:50 .... virtual supervision will change the workforce
58:50 .... CMS's virtual supervision has put the entire specialty of rad onc in danger

OK.

While it's possible some hospitals would make their RadOncs punch a clock...
FWIW at a small rural hospital I was at for a good period of time, I as the solo rad onc was certainly required to sign in and out (on a sheet of paper), daily, with notated times. Because an attorney told the CEO this was required of the rad onc (but no other doctor in the hospital).
 
  • Sad
Reactions: 1 user
I just don’t see how there is a workable mechanism for a percent of supervision presence from cms’ perspective. And they are not going to have complicated carve out for radonc. also very likely that the cms burueocracts think Dave Adler and Astro are a bunch of losers.

If the theory is that this is all being done to preserve technical reimbursement, why would CMS NOT continue virtual/general? They need to reduce expenditures. If they can get away with keeping direct supervision at bay and use that to justify cutting, why would they not do it? Shouldn't the burden be on ASTRO to explain why the supervision level is not what justifies the reimbursement (since it's obviously not) rather than just fight for direct supervision, which is basically admitting that reimbursement SHOULD BE tied to supervision level?
 
  • Like
Reactions: 2 users
One cynical way to look at this, is ASTRO is doing this so they can avoid doing anything about expansion and oversupply. They love the cheap labour warm bodies. They will not let them go. The breadlines will be here by time they choose to address it.
 
  • Like
  • Love
Reactions: 6 users
Previous ASTRO CEO chosen because of relationship with American Hospital Association and Big Medicine. Some considered it a lateral move at the time.

Yea. My take away from our discussion is that do not be so confident to believe that just because you are a good physician means you will be a good leader, negotiator, lobbyist, etc.

However, Id just counter with the fact that there are so. many. people in these roles in the US that have never set foot in a clinic. Thats a huge problem. If you read this board for 3 seconds, you see multiple times that ASTRO decided to "stick up for" the hospital over the physician.

If you read history, there are many examples where physicians (i.e. the AMA) lobbied for themselves over their patients, but in 2024 the pendulum has swung way too far toward focus on business aspects and away from clinical care.

In a time when radiation oncology has tons of consolidation, non-competes, workforce concerns and an increasingly scarce private practice environment, hire an MD! The hospitals have plenty of support in our field.
 
  • Like
Reactions: 3 users
If I had a magic wand and became ASTRO, I would do one thing:

A massive, thundering, pro-radiation PR campaign.

Pull in Varian and Elekta, MIM, Radformation, Civco - even my mortal enemy, the Goo Guys.

For the next 3-5 years, all we should hear about is the safety, efficacy, and VALUE that radiotherapy brings to the table.

And it needs to be done SO THE ACTUAL REST OF THE WORLD SEES IT.

Because the Spring edition of "ASTRO News" came out this week.

It's dedicated to benign radiotherapy. Including arthritis.

Does anyone know that?

I'm not a member so I don't get any emails. I follow ASTRO's website and social media presence closely, though.

You can find it on the website if you go specifically looking for it.

But...this is a very positive, important thing they did.

Don't they want anyone to know about it?
Ok so i just thumbed through this because I remain a member (ducks) and its really well done. It has evidence, practical advice and coding information.

if someone from ASTRO leadership is reading this, figure out a way to get that ASTRO news more widely disseminated.
 
  • Like
  • Haha
Reactions: 2 users
ASTRO publicly posted the town hall recording.


HIGHLIGHTS:
18:30 .... @Rad Onc SK says we are in a supervision nirvana, and it must end
22:50 .... virtual supervision will change the workforce
58:50 .... CMS's virtual supervision has put the entire specialty of rad onc in danger

OK.


FWIW at a small rural hospital I was at for a good period of time, I as the solo rad onc was certainly required to sign in and out (on a sheet of paper), daily, with notated times. Because an attorney told the CEO this was required of the rad onc (but no other doctor in the hospital).

I watched it all.

Good for them for posting.

My biggest red flag was how surprised they were about how much feedback /reaction they got from this letter. Seems extremely out of touch.

Otherwise, they explained some things fairly well.
 
  • Like
Reactions: 1 users
Ok so i just thumbed through this because I remain a member (ducks) and its really well done. It has evidence, practical advice and coding information.

if someone from ASTRO leadership is reading this, figure out a way to get that ASTRO news more widely disseminated.

If ASTRONews starts coming in the mail with Oncology Today and the Cleveland Clinic Hawaii CME Conference O' The Month post card Im gonna lose it.
 
  • Like
Reactions: 1 users
One cynical way to look at this, is ASTRO is doing this so they can avoid doing anything about expansion and oversupply. They love the cheap labour warm bodies. They will not let them go. The breadlines will be here by time they choose to address it.
Plausible deniability

“Look guys. WE TRIED. Don’t blame us things are shee-tay. We threw out a life preserver and you ungratefuls threw it back at us.”
 
  • Like
  • Love
Reactions: 1 users
Jordan Johnson rocking a Pablo Escobar painting in his office was something.
 
  • Haha
  • Love
Reactions: 4 users
This system only functions based on honor and fear.
Everything works on honor and fear. Without these, there is no social contract of any sort.
And it doesn't matter anyway because ASTRO is a joke to CMS, Virtual Direct will be permanent.
I agree that ASTRO has limited influence on CMS. But ASTRO, at present, has a fairly large impact on radonc culture and the establishment of standards that are not "legally based" but are often clinically implemented.

ASTRO is not going to bring a case against anyone. But, if your admin values your physical presence, they could reference ASTRO guidance to help set work expectations. They could even make a bit of a legal argument, stating that while CMS allows for virtual direct for billable services, the de-facto standard of care is really established through professional consensus, and at least one professional society has gone on the record establishing in-person direct supervision as standard. Fortunately or unfortunately

The point being...ASTRO doesn't need CMS to make an impact on real practice expectations or even on the perceived threat of legal action.

Per the NIH...The standard of care is a legal term, not a medical term. Basically, it refers to the degree of care a prudent and reasonable person would exercise under the circumstances.

The widespread adoption of virtual direct is what will protect virtual services legally, and it will change the workforce landscape incredibly (undeniable). In an environment where virtual becomes standard practice, it will be harder and harder for the individual rural radonc (or any radonc or doc period) to demonstrate value over virtual alternatives branded under larger institutions.

Doc X is willing to come in three days/week in person and work their tail off for us. He costs 850K/year. But the XYZ network has offered us branded, virtual services with in-person service provided by a shared APP...cost is 750K/year plus I get to put the XYZ logo up.
 
  • Like
Reactions: 4 users
The widespread adoption of virtual direct is what will protect virtual services legally, and it will change the workforce landscape incredibly (undeniable).


lot of folks here denying!
 
  • Like
Reactions: 1 user
Everything works on honor and fear. Without these, there is no social contract of any sort.

I agree that ASTRO has limited influence on CMS. But ASTRO, at present, has a fairly large impact on radonc culture and the establishment of standards that are not "legally based" but are often clinically implemented.

ASTRO is not going to bring a case against anyone. But, if your admin values your physical presence, they could reference ASTRO guidance to help set work expectations. They could even make a bit of a legal argument, stating that while CMS allows for virtual direct for billable services, the de-facto standard of care is really established through professional consensus, and at least one professional society has gone on the record establishing in-person direct supervision as standard. Fortunately or unfortunately

The point being...ASTRO doesn't need CMS to make an impact on real practice expectations or even on the perceived threat of legal action.

Per the NIH...The standard of care is a legal term, not a medical term. Basically, it refers to the degree of care a prudent and reasonable person would exercise under the circumstances.

The widespread adoption of virtual direct is what will protect virtual services legally, and it will change the workforce landscape incredibly (undeniable). In an environment where virtual becomes standard practice, it will be harder and harder for the individual rural radonc (or any radonc or doc period) to demonstrate value over virtual alternatives branded under larger institutions.

Doc X is willing to come in three days/week in person and work their tail off for us. He costs 850K/year. But the XYZ network has offered us branded, virtual services with in-person service provided by a shared APP...cost is 750K/year plus I get to put the XYZ logo up.
Well, this is directly related to a bigger concern/point I have on several topics, not just supervision.

I think a version of this future is coming no matter what.

I think that, instead of preparing the field of Radiation Oncology for this future, ASTRO is trying to desperately hold onto the past. Or, in the case of supervision, bring back the increasingly distant past.

This has basically never worked in the history of markets/capitalism/society/etc, whatever you want to call it.

Even if ASTRO "succeeds", it won't matter. A version of this future is coming, likely faster than we know.
 
  • Like
Reactions: 1 users
This has basically never worked in the history of markets/capitalism/society/etc, whatever you want to call it.
Bay Pilots.

Of course they were on the ship that rammed the Francis Scott Key bridge (A rare event, I'm sure the shipping company is happy the Bay Pilot was on board!)

To an outsider, the in-person presence of Bay Pilots seemingly superfluous for years (development of high end GPS technology).

Teachers...of higher education. Let everyone learn orgo from the best prof at MIT.

It's not clear to me that insisting on a physical, human presence is not in fact an ethical salvo against the technological encroachment on human values.
 
  • Hmm
Reactions: 1 user
...what?

Literally no one is denying that.

Of course it will.

okay.

there have been many posts saying that people are overreacting and that things have been this way since 2019 and nothing has happened so why do we care now?

we may have different definitions of literally no one.
 
okay.

there have been many posts saying that people are overreacting and that things have been this way since 2019 and nothing has happened so why do we care now?

we may have different definitions of literally no one.
Perhaps?

The way this is being framed is that this is some kind of change, as in, we will be moving into a world where Virtual Direct/General is "the norm". As in, the "threat" is in the future.

I see it as the change happened on January 1st, 2020, and then again in March/April 2020.

The consequences on any industry/workforce began many years ago. This is our status quo.

There were three options for ASTRO, really:

1) Do nothing
2) Acknowledge our legislative reality and craft a future-facing strategy for the field
3) Acknowledge our legislative reality and attempt to turn back the clock (uniquely, as it turns out)

Of the 3, the one they chose is the worst. Now we have to spend time and energy on this instead of something even mildly productive.
 
  • Like
Reactions: 1 user
It is crazy to think that just because things haven't been significantly abused in the past 4-5 years (while we were recovering from a pandemic mind you), that it will never happen. Virtual supervision without RadOncs on site will drastically increase the supply side and do nothing for the demand side, this will drive down the worth of physicians and employers will be psyched about it. It won't matter if it's worse for patients theoretically or actually.

The only way that it would possibly be able to be overcome is to not even be RadOncs anymore, but to become clinical oncs to raise our demand enough to offset the massive shift in supply demand that would surely lead to unemployment for many and plummet pay for a lot of RadOncs.

This is literally elementary economics.
 
  • Like
  • Love
Reactions: 7 users
This discussion exemplifies the QOL issue I've tried to verbalize: we're having a drawn out discussion that centers around the importance to our specialty of being sure we're expected to do something we all know we don't need to do.
 
  • Like
Reactions: 2 users
It is crazy to think that just because things haven't been significantly abused in the past 4-5 years (while we were recovering from a pandemic mind you), that it will never happen. Virtual supervision without RadOncs on site will drastically increase the supply side and do nothing for the demand side, this will drive down the worth of physicians and employers will be psyched about it. It won't matter if it's worse for patients theoretically or actually.

The only way that it would possibly be able to be overcome is to not even be RadOncs anymore, but to become clinical oncs to raise our demand enough to offset the massive shift in supply demand that would surely lead to unemployment for many and plummet pay for a lot of RadOncs.

This is literally elementary economics.
I think the abuse has already happened. That's my point. I don't think any of this matters.

Again, look at the voices active in this conversation. All the dirt this kicked up came from doctors mostly not at the 100 institutions with residency programs.

Meanwhile, ASTRO stands alone.

Where is SCAROP? Specifically, why haven't we heard from HROP, Anderson, Mayo, City of Hope, Moffitt, Sloan, UCSF, Penn...and on and on and on, voicing their support either way?

The only thing this does is rekindles the abuse of whistleblower cases and QoL for RadOncs "everywhere else", as in, not for the monster institutions trying to gobble up all the geography they can.

The outcome of this debate doesn't matter to the real boogeymen.

At all.
 
  • Like
Reactions: 3 users
It is crazy to think that just because things haven't been significantly abused in the past 4-5 years (while we were recovering from a pandemic mind you), that it will never happen. Virtual supervision without RadOncs on site will drastically increase the supply side and do nothing for the demand side, this will drive down the worth of physicians and employers will be psyched about it. It won't matter if it's worse for patients theoretically or actually.

The only way that it would possibly be able to be overcome is to not even be RadOncs anymore, but to become clinical oncs to raise our demand enough to offset the massive shift in supply demand that would surely lead to unemployment for many and plummet pay for a lot of RadOncs.

This is literally elementary economics.
the threat of supervision changes and hypofract/ommission has been vocally raised since at least 2018. Asto/scarop response has been to gas light.
 
  • Like
Reactions: 1 user
Top